- Home
- AFRI vs ANIK Comparison
AFRI vs ANIK Comparison
Compare AFRI & ANIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AFRI
- ANIK
- Stock Information
- Founded
- AFRI 1943
- ANIK 1983
- Country
- AFRI Gibraltar
- ANIK United States
- Employees
- AFRI N/A
- ANIK N/A
- Industry
- AFRI Packaged Foods
- ANIK Medical/Dental Instruments
- Sector
- AFRI Consumer Staples
- ANIK Health Care
- Exchange
- AFRI Nasdaq
- ANIK Nasdaq
- Market Cap
- AFRI 231.2M
- ANIK 196.6M
- IPO Year
- AFRI N/A
- ANIK 1993
- Fundamental
- Price
- AFRI $8.55
- ANIK $14.02
- Analyst Decision
- AFRI
- ANIK Buy
- Analyst Count
- AFRI 0
- ANIK 2
- Target Price
- AFRI N/A
- ANIK $22.00
- AVG Volume (30 Days)
- AFRI 12.1K
- ANIK 77.6K
- Earning Date
- AFRI 04-30-2025
- ANIK 05-07-2025
- Dividend Yield
- AFRI N/A
- ANIK N/A
- EPS Growth
- AFRI N/A
- ANIK N/A
- EPS
- AFRI N/A
- ANIK N/A
- Revenue
- AFRI $325,098,000.00
- ANIK $119,907,000.00
- Revenue This Year
- AFRI N/A
- ANIK N/A
- Revenue Next Year
- AFRI N/A
- ANIK $8.72
- P/E Ratio
- AFRI N/A
- ANIK N/A
- Revenue Growth
- AFRI 15.94
- ANIK N/A
- 52 Week Low
- AFRI $8.05
- ANIK $12.83
- 52 Week High
- AFRI $12.00
- ANIK $29.12
- Technical
- Relative Strength Index (RSI)
- AFRI 46.07
- ANIK 41.05
- Support Level
- AFRI $8.50
- ANIK $13.14
- Resistance Level
- AFRI $9.10
- ANIK $14.32
- Average True Range (ATR)
- AFRI 0.42
- ANIK 0.92
- MACD
- AFRI 0.03
- ANIK 0.02
- Stochastic Oscillator
- AFRI 47.12
- ANIK 45.42
About AFRI Forafric Global PLC
Forafric Global PLC is engaged in production and sale of a variety of wheat flours, Semolina and Pasta and Couscous in Morocco and in more than 45 countries. The two main brands in Morocco are MAYMOUNA and TRIA. The company derives majority of its revenue from Soft wheat.
About ANIK Anika Therapeutics Inc.
Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States and also has its presence in Europe and Other countries.